News
-
-
COMMUNIQUÉ DE PRESSE
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Zomedica Corp.'s PulseVet Shock Wave Device named Official Shock Wave Therapy Supplier of US Equestrian team veterinarians for major international team events. Partnership with USEF to enhance equine athlete care -
COMMUNIQUÉ DE PRESSE
NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections
NanoViricides, Inc. elaborates on its lead broad-spectrum antiviral drug candidate NV-387, poised to revolutionize viral disease treatment. Plans include Phase II studies for RSV and market expansion -
-
-
COMMUNIQUÉ DE PRESSE
DM1 au BP 2024
-
-
COMMUNIQUÉ RÉGLEMENTÉ
GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres Du 24 juin 2024 au 28 juin 2024
Déclaration hebdomadaire des transactions sur actions propres de Guillemot Corporation S.A. du 24/06/2024 au 28/06/2024. Transactions conformes à la réglementation -
-